Suffering

U.S. Topical Pain Relief Market by Therapeutic Class, Type, Formulation, and Distribution Channel: Opportunity Analysis and Industry Forecast, 2018-2025

Retrieved on: 
Tuesday, October 22, 2019
Organ systems, Perception, Acute pain, Analgesics, Nociception, Pain, Suffering, Peripheral neuropathy, Diabetic neuropathy, Over-the-counter drug, Salonpas

The growth of the U.S. topical pain relief market is majorly driven by increase in prevalence of arthritis and other bone-related conditions, diabetic neuropathy, leading to pain.

Key Points: 
  • The growth of the U.S. topical pain relief market is majorly driven by increase in prevalence of arthritis and other bone-related conditions, diabetic neuropathy, leading to pain.
  • The U.S. topical pain relief market is segmented based on therapeutic class, type, formulation, and distribution channel.
  • By type, the U.S. topical pain relief market is segmented into prescription pain relief and over-the-counter (OTC) relief.
  • Over-the-counter pain relief segment accounted for the largest market share in 2017 due to easy availability and high demand for topical pain relief products by sportsperson.

Global Acute Pain Epidemiology Forecast to 2028 | Patient Segmentation, Disease Risk & Burden, Risk of Disease by Severity - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 16, 2019
Health, Other Health, Perception, Acute pain, Nociception, Pain, Suffering, Surgery

The acute pain epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries.

Key Points: 
  • The acute pain epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries.
  • The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [segmented by Total Patient Pool with Acute Pain by Medical Condition and Severity Specific Patient Pool of Acute Pain] scenario of acute pain in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan from 2017 to 2028.
  • The author's epidemiology model for Acute Pain has assessed the total patient pool with Acute Pain, based on the proportion of population undergoing surgery, trauma injury and other medical illness, respectively.
  • Furthermore, among the patients with trauma injury in the US, 34,068,366 patients were contributed to the Acute Pain patient population.

Study Using Karuna Labs' Virtual Embodiment Training™ Reveals Mirror Visual Feedback Influences on Pain-Free Range of Motion

Retrieved on: 
Wednesday, October 16, 2019
Pain, Perception, Nociception, Acute pain, Virtual reality, Chronic pain, Pain management, Chronic condition, Suffering

The findings come from Karuna Labs , creator of personalized functional restoration and chronic pain management programs using VR technology to retrain the brain.

Key Points: 
  • The findings come from Karuna Labs , creator of personalized functional restoration and chronic pain management programs using VR technology to retrain the brain.
  • This study provides a framework to investigate whether training MVF in VR can improve function in chronic pain patients whose range of motion is limited by pain.
  • "These study results using our proprietary VR technology have immense implications for rehabilitation in patients suffering from chronic pain," said Lincoln Nguyen, CEO of Karuna Labs.
  • Karuna Labs creates personalized chronic pain management programs using Virtual Reality (VR) technology that retrains the brain to perceive movement as non-threatening.

NeuroMetrix Announces Updates to Quell 2.0 Commercial Strategy

Retrieved on: 
Tuesday, October 15, 2019
Pain, Perception, Nociception, Acute pain, Medical terminology, Quell, Chronic pain, Pain management, Chronic condition, Suffering

WOBURN, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company that develops and commercializes products for the chronic pain and diabetes markets, today announcedimportant updates to its Quell 2.0 commercial strategy.

Key Points: 
  • WOBURN, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company that develops and commercializes products for the chronic pain and diabetes markets, today announcedimportant updates to its Quell 2.0 commercial strategy.
  • This streamlined distribution model will allow more people with chronic pain to benefit from the advanced Quell pain relief technology.
  • Quell also offers health tracking metrics relevant to chronic pain sufferers, including pain, sleep, activity, and gait.
  • Quell users can synchronize their data with the Quell Health Cloud, which provides customized feedback and powers one of the worlds largest chronic pain databases.

5 Tips to Take Control of Your Pain

Retrieved on: 
Wednesday, October 9, 2019
Perception, Acute pain, Senses, Nociception, Suffering, Pain

From limiting your daily activities, to straining your closest relationships, pain has a way of taking control.

Key Points: 
  • From limiting your daily activities, to straining your closest relationships, pain has a way of taking control.
  • That's why therapeutic at-home massager manufacturer Wahl interviewed board-certified anesthesiologist and pain specialist Dr. Anita Gupta for tips on how to get the power back.
  • "Taking control of painful symptoms is challenging under even the best of circumstances," explains Dr. Gupta.
  • Clarifying roles and responsibilities for yourself and those within your support network can ease anxieties that could exacerbate pain.

Nocimed Announces First Commercial Clients for New Non-Invasive Spinal Pain Assessment Tool In North America and Europe

Retrieved on: 
Tuesday, September 17, 2019
Pain, Perception, Senses, Acute pain, Nociception, Suffering, Back pain

"Using NociScan has increased our understanding of the underlying causes of the pain experienced with our patients.

Key Points: 
  • "Using NociScan has increased our understanding of the underlying causes of the pain experienced with our patients.
  • We expect to use this knowledge to help make faster and better clinical decisions, which will improve patients' lives."
  • Seeing NociScan being used in Europe and North America is rewarding, because Nocimed is living up to its promise of helping diagnose lower back pain.
  • Nocimed is registered with FDA and has a CE Mark in Europe and so is selling in the US and EU.

United States Acute Pain Market and Competitive Landscape Report 2019

Retrieved on: 
Friday, September 6, 2019
Perception, Nervous system, Senses, Acute pain, Nociception, Suffering, Pain

DUBLIN, Sept. 6, 2019 /PRNewswire/ -- The "US Acute Pain Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Sept. 6, 2019 /PRNewswire/ -- The "US Acute Pain Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.
  • US Acute Pain Market and Competitive Landscape Highlights - 2019, provides comprehensive insights into Acute Pain pipeline products, Acute Pain epidemiology, Acute Pain market valuations and forecast, Acute Pain drugs sales and competitive landscape in the US.
  • Acute Pain pipeline: Find out the products in clinical trials for the treatment of Acute Pain by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
    Acute Pain drugs: Identify key products marketed and prescribed for Acute Pain in the US, including trade name, molecule name, and company
    Acute Pain market valuations: Find out the market size for Acute Pain drugs in 2018 in the US.
  • Find out how the market advanced from 2014 and forecast to 2024
    Acute Pain drugs market share: Find out the market shares for key Acute Pain drugs in the US
    Evaluate commercial market opportunity assessment, positioning, and segmentation for Acute Pain products

Top Minds in Chronic Pain Gather at Napa Pain Conference

Retrieved on: 
Wednesday, August 28, 2019
Perception, Acute pain, Senses, Suffering, Nociception, Pain, Neurology

NAPA, Calif., Aug. 28, 2019 /PRNewswire/ --The world's top scientists, physicians, policy-makers and researchers in the field of pain gathered to attend the 26th Annual Napa Pain Conference (NPC) this past week.

Key Points: 
  • NAPA, Calif., Aug. 28, 2019 /PRNewswire/ --The world's top scientists, physicians, policy-makers and researchers in the field of pain gathered to attend the 26th Annual Napa Pain Conference (NPC) this past week.
  • Our goal with the Napa Pain Conference is to get innovation into practice as quickly as possible," said CEO and Founder of Neurovations , Dr. Eric Grigsby.
  • "At the time I started the Napa Pain Conference in 1990, pain management was an unknown.
  • The conference will address cutting-edge science and technology for patient care including treatment of pain, disease neurological and psychiatric disorders.

Pain Management Therapeutics Market is Likely to Clock a CAGR of 4.0%, Booming Healthcare Industry to Create a Positive Growth Environment Globally - TMR

Retrieved on: 
Friday, August 23, 2019
Perception, Pain, Senses, Acute pain, Nociception, Suffering, Cancer pain, Palliative care

Currently, with large number of players participating in the market, the global pain management therapeutics market has a fragmented vendor landscape.

Key Points: 
  • Currently, with large number of players participating in the market, the global pain management therapeutics market has a fragmented vendor landscape.
  • Increased awareness about the cancer pain therapeutics is driving growth in the pain management therapeutics market globally.
  • Thus, increasing number of cancer cases and cancer pain is augmenting growth in the global pain management therapeutics market.
  • Lucrative reimbursement for pain management treatment along with rising demand for palliative care treatment is further befitting growth in the pain management therapeutics market.

Global Cold Pain Therapy Market Analysis, Trends, and Forecasts 2019-2025: Market is Projected to Grow by $666 Thousand

Retrieved on: 
Monday, August 12, 2019
Perception, Health sciences, Health, Acute pain, Nociception, Pain, Suffering, Therapy

DUBLIN, Aug. 12, 2019 /PRNewswire/ -- The "Cold Pain Therapy - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 12, 2019 /PRNewswire/ -- The "Cold Pain Therapy - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
  • Cold Pain Therapy market worldwide is projected to grow by US$666.6 Thousand, guided by a compounded growth of 4.8%.
  • The report addresses this very need and provides the latest scoop on all major market segments.
  • OTC Products, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.2%.